CLPTM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.21804821573824E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.11939404599116E-12 |
Normal-vs-Stage2 |
1.42940004277392E-09 |
Normal-vs-Stage3 |
8.88178419700125E-15 |
Normal-vs-Stage4 |
7.68159980069072E-11 |
Stage1-vs-Stage2 |
1.652800E-01 |
Stage1-vs-Stage3 |
1.188100E-02 |
Stage1-vs-Stage4 |
7.014400E-02 |
Stage2-vs-Stage3 |
6.764200E-01 |
Stage2-vs-Stage4 |
7.442600E-01 |
Stage3-vs-Stage4 |
9.890200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
2.827400E-04 |
Normal-vs-Asian |
5.888800E-01 |
Caucasian-vs-AfricanAmerican |
6.475500E-02 |
Caucasian-vs-Asian |
4.391600E-01 |
AfricanAmerican-vs-Asian |
7.105600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
2.00519999493665E-08 |
Male-vs-Female |
4.01030000000135E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.29389999995E-07 |
Normal-vs-Age(41-60Yrs) |
2.53774778968818E-12 |
Normal-vs-Age(61-80Yrs) |
1.75115477674126E-12 |
Normal-vs-Age(81-100Yrs) |
3.28890000000914E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.262800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.562200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.530800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.721000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.852200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.301600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.237010E-01 |
Normal-vs-Grade 2 |
1.06203934535642E-12 |
Normal-vs-Grade 3 |
7.70494779089859E-14 |
Normal-vs-Grade 4 |
1.91746618583011E-12 |
Grade 1-vs-Grade 2 |
4.131900E-02 |
Grade 1-vs-Grade 3 |
3.514400E-02 |
Grade 1-vs-Grade 4 |
6.559700E-03 |
Grade 2-vs-Grade 3 |
6.937600E-01 |
Grade 2-vs-Grade 4 |
1.021760E-01 |
Grade 3-vs-Grade 4 |
1.955030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62492241884138E-12 |
Normal-vs-ccB subtype |
2.9251046029799E-12 |
ccA subtype-vs-ccB subtype |
9.884200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.67321712041257E-12 |
Normal-vs-N1 |
2.801700E-02 |
N0-vs-N1 |
8.622200E-01 |
|
|